# AeriSeal® System for Lung Volume Reduction in Patients With Advanced Emphysema

> **NCT01181466** · PHASE2,PHASE3 · COMPLETED · sponsor: **Aeris Therapeutics** · enrollment: 20 (actual)

## Conditions studied

- Pulmonary Emphysema
- COPD
- Lung Diseases

## Interventions

- **DEVICE:** AeriSeal System

## Key facts

- **NCT ID:** NCT01181466
- **Lead sponsor:** Aeris Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2011-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01181466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01181466, "AeriSeal® System for Lung Volume Reduction in Patients With Advanced Emphysema". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT01181466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*